Sign in
4/A

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-064323

Options or other derivatives

  • Director acquired 13,269 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Moin Andrew Director 2023-11-13 Grant or award · Series A-1 Convertible Preferred Stock +13,269 $1,000.00 $13,269,000 31,269 I
Loading xslF345X05/ownership.xml…